Department of Radiology, Chongqing University Cancer Hospital, Chongqing Key Laboratory for Intelligent Oncology in Breast Cancer, No. 181 Hanyu Rd, Shapingba District, Chongqing 400030, China
Auto-generated profile, based on publicly available information
Xiaoxia Wang
Department of Radiology, Chongqing University Cancer Hospital, Chongqing Key Laboratory for Intelligent Oncology in Breast Cancer, No. 181 Hanyu Rd, Shapingba District, Chongqing 400030, China
A nomogram model combining intratumoral heterogeneity score and clinicopathologic variables predicted pathologic complete response to neoadjuvant chemotherapy well, and nomogram scores were associated with recurrence-free survival and biologic pathways.
Time-dependent diffusion MRI–based microstructural mapping was shown to be an effective method in helping to identify molecular subtypes and predict pathologic complete response to neoadjuvant chemotherapy in participants with breast cancer.
To investigate the predictive value of MRI-based radiomics features for lymph node metastasis (LNM) and vascular endothelial growth factor (VEGF) expression in patients with cervical cancer. A total of 163 patients with cervical cancer were enrolled in this study. A total of 134 patients were included for LNM differentiation, and 118 were included for VEGF expression discrimination. The patients were randomly assigned to the training group or test group at a ratio of 2:1. Radiomics features were extracted from T1WI enhanced and T2WI MRI scans of each patient, and tumor stage was also documented according to the International Federation of Gynecology and Obstetrics (FIGO) guidelines. The least absolute shrinkage and selection operator algorithm was used for feature selection. The results of 5-fold cross validation were applied to select the best classification models. The performances of the constructed models were further evaluated with the test group. Sixteen radiomics features and the FIGO stage were selected to construct the LNM discrimination model. The LNM prediction model achieved the best diagnostic performance, with areas under the receiver operating curve (AUCs) of 0.95 and 0.88 in the training group and test group, respectively. Nine radiomics characteristics were screened to build the VEGF prediction model, with AUCs of 0.82 and 0.70 in the training group and test group, respectively. Decision curve analysis confirmed their clinical usefulness. The presented radiomics prediction models demonstrated potential to noninvasively differentiate LNM and VEGF expression in cervical cancer.
A diagnostic model combining tumor stiffness measured at MR elastography with clinical-radiologic variables showed the best performance for predicting lymphovascular space invasion in participants with endometrial cancer.
A model combining clinicopathologic variables and diffusion kurtosis imaging parameters after two cycles of neoadjuvant chemotherapy demonstrated excellent performance in predicting pathologic complete response in participants with breast cancer.